From: Salicylic acid derivatives as potential α-glucosidase inhibitors: drug design, molecular docking and pharmacokinetic studies
S/No
Structures
Predicted pIC50
Lead compound
3.32
A1
4.32
A2
4.80
A3
4.48
A4
5.11
A5
4.50